Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Cadence Pharmaceuticals Inc. (CADX)

-NasdaqGS

6.91 Down 0.06(0.86%) May 24, 4:00PM EDT|After Hours : 6.91 Up 0.00 (0.02%) May 24, 4:36PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 23,612   17,174   13,898   11,108  
Cost of Revenue8,167  7,178  6,076  5,756  
Gross Profit 15,445   9,996   7,822   5,352  
Operating Expenses
Research Development1,363  1,073  2,235  1,700  
Selling General and Administrative21,685  21,192  20,052  23,242  
Non Recurring -  7,723   -   -  
Others336  335  336  336  
Total Operating Expenses -  30,323   -   -  
Operating Income or Loss (7,939) (20,327) (14,801) (19,926)
Income from Continuing Operations
Total Other Income/Expenses Net7,676  24  33  47  
Earnings Before Interest And Taxes(263)(20,303)(14,768)(19,879)
Interest Expense1,100  1,118  1,122  1,110  
Income Before Tax(1,363)(21,421)(15,890)(20,989)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,363)(21,421)(15,890)(20,989)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,363) (21,421) (15,890) (20,989)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,363) (21,421) (15,890) (20,989)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.